Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model
Crossref DOI link: https://doi.org/10.1186/s13075-016-0931-3
Published Online: 2016-01-23
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Atkinson, Sara Marie
Bleil, Janine
Maier, René
Kühl, Anja A.
Thorn, Mette
Serikawa, Kyle
Fox, Brian
Kruse, Kim
Haase, Claus
Skov, Søren
Nansen, Anneline
Syrbe, Uta
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft ((Sy 31/3-2) SPP 1486 Immunobone.)